← Back to Search

Behavioral Intervention

Parent training for Medically Unexplained Symptoms

N/A
Waitlist Available
Led By Wendy Silverman, Ph.D.
Research Sponsored by Yale University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Presence of medically unexplained symptoms, including: fibromyalgia, chronic fatigue, chronic Lyme disease, irritable bowel syndrome, musculoskeletal pain, headache, abdominal pain and related bowel dysfunction, perceived cognitive impairment, or other nonspecific symptoms
Symptoms must have been present for at least 3 months, associated with some degree of impairment (e.g., missing school), and not attributable to a known organic or medical disorder despite adequate evaluation
Timeline
Screening 3 weeks
Treatment Varies
Follow Up pre-treatment; post-treatment; 3-month follow-up
Awards & highlights

Study Summary

This trial is testing a parent-only intervention to help youth with chronic unexplained medical symptoms. The goal is to see if it decreases symptoms and parent stress while being feasible for parents.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
You have unexplained physical symptoms such as chronic fatigue, pain, headaches, or digestive problems that cannot be diagnosed by a doctor.
Select...
You have been experiencing symptoms for at least 3 months that are affecting your daily life (like missing school), and doctors have ruled out any known medical causes.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~pre-treatment; post-treatment; 3-month follow-up
This trial's timeline: 3 weeks for screening, Varies for treatment, and pre-treatment; post-treatment; 3-month follow-up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Client Satisfaction Questionnaire (CSQ-8; Attkisson & Greenfield, 1996)
Secondary outcome measures
Affective Reactivity Index-Child and Parent versions (ARI-C/P; Stringaris, Goodman, Ferdinando, Razdan, Muhrer, Leibenluft, & Brotman, 2012)
Child Anxiety Sensitivity Index (CASI; Silverman, Fleisig, Rabian, & Peterson, 1991)
Child's Report of Parental Behavior Inventory (CRPBI; Schludermann & Schludermann, 1988)
+11 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Parent trainingExperimental Treatment1 Intervention
Parents of participating children with chronic symptoms will receive the intervention in a virtual group format. Groups will last 90-minutes and run for 6-8 weeks. Groups will be co-led by a clinical psychologist and pediatric physician with expertise in child behavioral interventions and medically unexplained symptoms.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Parent training
2013
N/A
~230

Find a Location

Who is running the clinical trial?

Wallace Research FoundationUNKNOWN
2 Previous Clinical Trials
21 Total Patients Enrolled
Yale UniversityLead Sponsor
1,837 Previous Clinical Trials
2,728,397 Total Patients Enrolled
Wendy Silverman, Ph.D.Principal InvestigatorYale University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who meets the prerequisites to partake in this clinical trial?

"This clinical investigation is open to 24 minors aged 10-17 who are experiencing unverified medical issues with a measurable degree of distress. To qualify, children must have been symptomatic for at least three months and live with their participating parent(s) no less than half the time. Eligible applicants will be dealing with ailments such as fibromyalgia, chronic fatigue syndrome, Lyme disease, irritable bowel syndrome (IBS), musculoskeletal pain, headache, abdominal pain and associated digestive disorders, cognitive impairment or other nonspecific symptoms that cannot be linked to any known organic ailment after exhaustive examination."

Answered by AI

Are participants of any age eligible to join this research program?

"The parameters for entry into this trial are that prospective participants must be between 10 and 17 years of age. Additionally, there are 2 studies tailored specifically to younger individuals and 8 more designed with older populations in mind."

Answered by AI

What is the highest quantity of participants that are enrolled in this medical experiment?

"Affirmative. According to information published on clinicaltrials.gov, this medical trial which was first posted in April 2021 is still recruiting patients. 24 participants are needed from one location."

Answered by AI

Are applications being accepted at the moment for this research endeavor?

"According to clinicaltrials.gov, this research initiative is currently enrolling individuals. Originally posted on April 5th 2021, the study was recently updated on August 10th 2022."

Answered by AI
~4 spots leftby Mar 2025